ALLANTOIN

N/A

Manufactured by Skinfix, Inc.

9,609 FDA adverse event reports analyzed

Last updated: 2026-04-15

About ALLANTOIN

ALLANTOIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Skinfix, Inc.. The most commonly reported adverse reactions for ALLANTOIN include NAUSEA, VOMITING, CONDITION AGGRAVATED, DYSPNOEA, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ALLANTOIN.

Top Adverse Reactions

NAUSEA388 reports
VOMITING268 reports
CONDITION AGGRAVATED210 reports
DYSPNOEA199 reports
DRUG INEFFECTIVE198 reports
ABDOMINAL PAIN186 reports
WEIGHT DECREASED175 reports
SOMNOLENCE169 reports
FATIGUE168 reports
DIZZINESS160 reports
HEADACHE151 reports
ANAEMIA149 reports
CONSTIPATION148 reports
ASTHENIA145 reports
BLOOD GLUCOSE INCREASED143 reports
SEPSIS142 reports
ABDOMINAL DISTENSION135 reports
HYPONATRAEMIA132 reports
DIARRHOEA131 reports
PAIN130 reports
GENERAL PHYSICAL HEALTH DETERIORATION127 reports
DRY MOUTH122 reports
PYREXIA122 reports
STRESS118 reports
ASCITES115 reports
OFF LABEL USE113 reports
PNEUMONIA111 reports
VENTRICULAR FIBRILLATION110 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME109 reports
OEDEMA PERIPHERAL108 reports
APPENDICITIS105 reports
DRUG HYPERSENSITIVITY104 reports
DIABETES MELLITUS103 reports
APPENDICOLITH101 reports
HYPOTENSION101 reports
CARDIOGENIC SHOCK100 reports
HYPERTENSION98 reports
PULMONARY EMBOLISM98 reports
BLOOD PHOSPHORUS INCREASED96 reports
THROMBOSIS94 reports
CHRONIC OBSTRUCTIVE PULMONARY DISEASE93 reports
FALL93 reports
DRUG INTOLERANCE92 reports
TREMOR90 reports
SWELLING89 reports
MYASTHENIA GRAVIS87 reports
BLOOD CHOLESTEROL INCREASED86 reports
SLEEP DISORDER86 reports
NEURALGIA85 reports
BACTERIAL INFECTION84 reports
CONFUSIONAL STATE81 reports
DEATH81 reports
PHARMACEUTICAL PRODUCT COMPLAINT81 reports
HYPOPHOSPHATAEMIA80 reports
DECREASED APPETITE78 reports
HYPERPHOSPHATAEMIA78 reports
INTENTIONAL PRODUCT MISUSE78 reports
INSOMNIA77 reports
DEPRESSION76 reports
RASH74 reports
BLOOD URIC ACID INCREASED73 reports
INCORRECT ROUTE OF PRODUCT ADMINISTRATION73 reports
ANXIETY72 reports
BLOOD CREATININE INCREASED72 reports
CHEST PAIN72 reports
DEHYDRATION72 reports
MALAISE70 reports
PAIN IN EXTREMITY70 reports
CONVULSION69 reports
FEELING ABNORMAL69 reports
ARTHRALGIA67 reports
ASPARTATE AMINOTRANSFERASE INCREASED62 reports
PRODUCT USE IN UNAPPROVED INDICATION59 reports
ABDOMINAL PAIN UPPER58 reports
LOSS OF CONSCIOUSNESS58 reports
PLEURAL EFFUSION58 reports
RENAL FAILURE ACUTE58 reports
ANALGESIC THERAPY57 reports
IRON DEFICIENCY57 reports
HYPERHIDROSIS55 reports
DRUG THERAPY54 reports
SLEEP DISORDER THERAPY54 reports
ATRIAL FIBRILLATION51 reports
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED50 reports
GOUT50 reports
MUSCULOSKELETAL STIFFNESS50 reports
CHILLS49 reports
BACK PAIN48 reports
ULCER48 reports
HAEMOGLOBIN DECREASED47 reports
HYPERLIPIDAEMIA47 reports
PRURITUS47 reports
HYPOAESTHESIA46 reports
PLATELET COUNT DECREASED46 reports
RENAL FAILURE46 reports
VISION BLURRED46 reports
BLOOD GLUCOSE DECREASED45 reports
DRUG INTERACTION45 reports
MYALGIA45 reports
BLOOD PRESSURE INCREASED43 reports

Report Outcomes

Out of 3,240 classified reports for ALLANTOIN:

Serious 76.7%Non-Serious 23.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1,693 (53.8%)
Male1,441 (45.8%)
Unknown12 (0.4%)

Reports by Age

Age 80164 reports
Age 5965 reports
Age 6764 reports
Age 5563 reports
Age 5859 reports
Age 4958 reports
Age 5658 reports
Age 6857 reports
Age 6156 reports
Age 7055 reports
Age 7252 reports
Age 5351 reports
Age 7451 reports
Age 6450 reports
Age 5749 reports
Age 6648 reports
Age 7848 reports
Age 5046 reports
Age 5446 reports
Age 6046 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ALLANTOIN?

This profile reflects 9,609 FDA FAERS reports that mention ALLANTOIN. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ALLANTOIN?

Frequently reported terms in FAERS include NAUSEA, VOMITING, CONDITION AGGRAVATED, DYSPNOEA, DRUG INEFFECTIVE, ABDOMINAL PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ALLANTOIN?

Labeling and FAERS entries often list Skinfix, Inc. in connection with ALLANTOIN. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.